See how fibroblast culture on macroporous polymeric scaffolds produces collagen-rich leather, r
Controlled 3D stem cell differentiation forms scaffold-free beating heart tissue with a chamber-like cavity and high cardiac cell purity.
Delipidated, decellularized adipose and fascia matrices improve implant volume retention while lowering rejection risk in soft tissue repair.
Growth factor-treated acellular lung scaffolds and bioreactor recellularization build perfusable vessels that support long-term BEL survival.
Continuous cell recovery and media exchange keep suspension bioreactors productive at high cell density while sterile output modules prevent backflow contamination.
Neonatal pig-derived mesenchymal stem cells improve treatment consistency and angiogenic activity while lowering pulmonary embolism risk.
Timed Gremlin2 and retinoic acid treatment drives hiPSCs toward mature, homogeneous atrial cardiomyocytes with adult-like morphology and signaling response.
Controlled pressure drives isolated mitochondria through a porous membrane to improve mtDNA uptake while minimizing cell damage and contamination.
Co-culturing dental epithelial and mesenchymal cells in hydrogel supports enables reproducible hard tissue differentiation and regeneration confirmation.
Co-cultured hepatocyte clusters on feeder cells improve attachment and long-term liver function for drug metabolism, toxicity, and HBV studies.
SUSD2 High fibroblast selection and controlled culture density improve cardiac extracellular matrix purity, consistency, and integrity.
A cavity-based culture chamber lets cells integrate and grow beyond the chamber to form 3D tissue strong enough for suturing.
Gelatin microcapsules gain strength and oil retention through natural polymers and thickeners, supporting stable co-culture and cell maturation.
Specific surface markers enable isolation of atrial and ventricular cardiomyocytes from mixed cells, improving purity for targeted therapy.
A serum-free 3D somite culture path speeds pluripotent cell differentiation into muscle cells in two weeks while reducing growth factor cost.